Aquigen Bio Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
- Revenue Growth 33.20%
- Profit Growth 49.58%
- Ebitda 70.27%
- Net Worth 72.48%
- Total Assets 45.45%
About Aquigen Bio Science
Aquigen Bio Science Private Limited (ABSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 April 2018 (Six years and ten months 0 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 Cr.
Maruti Jagtap, Shashikant Bhorkade, and Archana Nikam serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999PN2018PTC176298
- Company No.
176298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Aquigen Bio Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maruti Jagtap  | Managing Director | 26-Apr-2018 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shashikant Bhorkade | Director | 26-Apr-2018 | Current |
| Archana Nikam | Director | 30-Nov-2021 | Current |
Financial Performance of Aquigen Bio Science.
Aquigen Bio Science Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 33.2% increase. The company also saw a substantial improvement in profitability, with a 49.58% increase in profit. The company's net worth Soared by an impressive increase of 72.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aquigen Bio Science?
Unlock access to Aquigen Bio Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2023 | Others | ₹1.50 Cr | Open |
How Many Employees Work at Aquigen Bio Science?
Aquigen Bio Science has a workforce of 0 employees as of Feb 19, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aquigen Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquigen Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.